Company news
MacroGenics, Inc. news in 2021
MacroGenics, Inc.'s news releases, calls and decks from 2021, newest first.
I-Mab Announces IND Approval from China NMPA for Phase 2 Clinical Trial of Enoblituzumab in Combination with Pembrolizumab in Solid Tumors
December 26, 2021
MacroGenics Provides Update on Corporate Progress and Third Quarter 2021 Financial Results
November 1, 2021
MacroGenics Announces Date of Third Quarter 2021 Financial Results Conference Call
October 25, 2021
MacroGenics Announces Preliminary Clinical Results from Phase 1 Cohort Expansion of the Ongoing MGC018 Study Presented at ESMO 2021 Virtual Annual Congress
September 15, 2021
MacroGenics Announces Clinical Results from Cohort A Part 1 of Phase 2/3 MAHOGANY Study of Margetuximab in Combination with Retifanlimab in Gastroesophageal Adenocarcinoma at ESMO 2021
September 15, 2021
MacroGenics Announces Presentations at ESMO 2021 Virtual Annual Congress
September 11, 2021
MacroGenics Announces Final Overall Survival Results from SOPHIA Study of MARGENZA™ in Patients with HER2-Positive Metastatic Breast Cancer
September 6, 2021
MacroGenics Provides Update on Corporate Progress and Second Quarter 2021 Financial Results
July 28, 2021
MacroGenics Announces Date of Second Quarter 2021 Financial Results Conference Call
July 21, 2021
Zai Lab and MacroGenics Enter Into Broad Strategic Collaboration to Develop and Commercialize Preclinical Bispecific Antibodies in Oncology
June 15, 2021
MacroGenics and Zai Lab Enter Into Broad Strategic Collaboration to Develop and Commercialize Preclinical Bispecific Antibodies in Oncology
June 15, 2021
MacroGenics Announces Preliminary Clinical Results from Phase 1 Study of MGC018 to be Presented at ASCO Annual Meeting
May 18, 2021
MacroGenics Provides Update on Corporate Progress and First Quarter 2021 Financial Results
April 28, 2021
MacroGenics Announces Date of First Quarter 2021 Financial Results Conference Call
April 18, 2021
Alligator Bioscience and MacroGenics Enter into a Research Collaboration to Develop a Novel Immunotherapy
April 14, 2021
MacroGenics Announces Presentations at the 2021 AACR Annual Meeting
April 9, 2021
MacroGenics Provides Update on Corporate Progress and 2020 Financial Results
February 24, 2021
MacroGenics Announces Date of Fourth Quarter and Full Year 2020 Financial Results Conference Call
February 17, 2021
MacroGenics Names Federica O’Brien to its Board of Directors
February 10, 2021
MacroGenics Announces Achievement of $10 Million Milestone Related to Retifanlimab Collaboration with Incyte
February 10, 2021
MacroGenics Announces Publication of SOPHIA Trial Results for MARGENZA™ in JAMA Oncology
January 24, 2021
Calls in 2021
Decks in 2021
- Technical Presentation (June 2021)
Technical · 36 slides · Jun 4, 2021